Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis. - Jin, Yanyan; Zhu, Jianhong; Sheng, Aiqin; Lin, Qian; Zhao, Manli; He, Xue; Mao, Jianhua; Fu, Haidong (Pediatric Nephrology, 2025)